ROSEN, A TOP RANKED LAW FIRM, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - DNA, SRNGNewsfile Corp • 11/22/21
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/22/21
GINKGO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 11/20/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 11/19/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 11/18/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 11/17/21
mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity CapabilitiesPRNewsWire • 11/17/21
Ginkgo Bioworks Holdings, Inc. (DNA) CEO Jason Kelly on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/15/21
GINKGO BIOWORKS INVESTOR ALERT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ginkgo Bioworks To Contact Him Directly To Discuss Their OptionsNewsfile Corp • 11/14/21
Ginkgo Bioworks Launches Cell Development Kit Service for Standardized, Low-Cost Entry to its Cell Programming PlatformPRNewsWire • 11/11/21
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of HomocystinuriaPRNewsWire • 11/09/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 11/03/21
Arcaea, a Company Launched on the Ginkgo Bioworks Platform, Announces $78M Series A To Build a New Foundation For the Beauty Industry through Expressive BiologyPRNewsWire • 10/27/21
Selecta Biosciences, Ginkgo Bioworks Join Forces To Develop Rare Disease TreatmentsBenzinga • 10/26/21
Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for Orphan and Rare DiseasesPRNewsWire • 10/26/21
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses To Contact the FirmNewsfile Corp • 10/25/21
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 10/21/21
Baillie Gifford Trimmed Positions In Alibaba, Tesla, Nio, Moderna In Q3, Here's What It Bought InsteadBenzinga • 10/21/21
